Amkay Products Ltd (AMKAY) — shareholding pattern, promoter holding, financials and share price
About Amkay Products Ltd (AMKAY)
Amkay Products Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as AMKAY and on the BSE under scrip code 544169. Its ISIN is INE0QSB01016.
Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products [1]
Amkay Products Ltd is a manufacturer and marketer of medical devices and healthcare products, serving centers, hospitals, clinics, and nursing homes in India.
The company has expanded its product line significantly from its initial offering, now including items like face masks, alcohol swabs, digital thermometers, and more.
Listed peers in Medical Equipment & Supplies: Royal Sense Ltd, Shree Pacetronix Ltd, KMS Medisurgi Ltd, GKB Ophthalmics Ltd, Centenial Surgical Suture Ltd, Galaxy Medicare Ltd.
Valuation & Returns
10 Jul 2026At ₹48.52 a share on 10 Jul 2026, Amkay Products Ltd (AMKAY) was valued at a price-to-earnings ratio of 18.18x against an industry P/E of 44.11x and a price-to-book of 1.59x on a book value of ₹30.47 per share. Solomo computes return on equity of 8.76% and return on capital employed of 11.99% from filed results.
- P/E
- 18.18x
- Industry P/E
- 44.11x
- P/B
- 1.59x
- EPS (TTM)
- ₹3.96
- Book value / share
- ₹30.47
- ROE
- 8.76%
- ROCE
- 11.99%
- ROA
- 6.93%
- Debt / equity
- 0.15x
- Dividend yield
- 0%
- EBITDA margin
- 10.75%
- 52-week range
- ₹39.22 – ₹81.99
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Amkay Products Ltd (AMKAY) reported revenue of ₹42.03 crore, net profit of ₹2.31 crore and earnings per share of ₹2.67. That compares with revenue of ₹38.39 crore and net profit of ₹3.34 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹19.02 crore and net profit ₹0.34 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 36.47 | 27.86 | 31.07 | 38.39 | 42.03 |
| Net profit (₹ cr) | 1.47 | 1.55 | 2.63 | 3.34 | 2.31 |
| EPS (₹) | 530.69 | 559.57 | 4.13 | 3.86 | 2.67 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 1.69% | 23.56% |
| Profit growth | 31.53% | 27.00% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 73.44% of Amkay Products Ltd (AMKAY) (unchanged from the previous quarter). Market capitalisation was ₹42 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2024.
Largest disclosed public shareholders in Jun 2026: THACKER MAHENDRA 1.83%, BHAVNA BHARAT THACKER 1.62%, BABITHA MENON 1.32%, KASHVI PRAKASH CHECHANI 1.22%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 73.44% | - | - | - | 26.56% |
| Mar 2026 | 73.44% | - | - | - | 26.56% |
| Dec 2025 | 73.44% | - | - | - | 26.56% |
| Sep 2025 | 73.44% | - | - | - | 26.56% |
| Jun 2025 | 73.44% | - | - | - | 26.56% |
| Mar 2025 | 73.44% | - | - | - | 26.56% |
| Dec 2024 | 73.44% | - | - | - | 26.56% |
| Sep 2024 | 73.44% | - | 0.16% | - | 26.56% |